[1]JournalofMedicinalChemistry,2007,vol.50,p.2225-2239
[1]Patent:WO2013/119946,2013,A1.Locationinpatent:Paragraph0532
[1]Patent:WO2013/119946,2013,A1
1384428-47-0
1251924-20-5
433219-55-7 | (+/-)-15-DEOXY-16R-HYDROXY-17-CYCLOBUTYL PROSTAGLANDIN E1 | AA00DA6L | MFCD05863943
453565-90-7 | 3-Bromo-5-trifluoromethoxybenzoic acid | AA00DAAQ | MFCD04116041
544440-95-1 | 3-CHLORO-N-(4-FLUORO-BENZYL)-PROPIONAMIDE | AA00DAH7 | MFCD03378039
457081-03-7 | Pyridone 6 | AA00DANX | MFCD17019334
441-28-1 | 2-(4-Fluoro-phenyl)-quinoline-4-carboxylic acid | AA00DART | MFCD00616372
53059-31-7 | 1-Methoxy-4-(3-nitrophenyl)benzene | AA00DAYP | MFCD08669842
476310-60-8 | VO-Ohpic trihydrate | AA00DB4Z | MFCD11045907
5496-10-6 | 1-Aminocyclohexanecarbonitrile | AA00DB9H | MFCD01937788
554423-28-8 | 4-(3,5-Dimethyl-piperidine-1-sulfonyl)-phenylamine | AA00DBEL | MFCD03980976
53333-76-9 | 2,2-DIMETHYLPROPANE-1-SULFONYL CHLORIDE | AA00DBJL | MFCD10697745